China NMPA Extends Drug Submission Time for Supplementing Materials

On October 14th, China’s National Medical Products Administration (NMPA) announced an extra 80 to 160 days extension for the submission …

read more...

Hong Kong DOH Updates the List of Refence Countries for Registration of Pharmaceutical Products

Hong Kong’s Pharmacy and Poisons Board reviewed the requirements of the list of reference countries for the registration of pharmaceutical …

read more...

Thailand FDA Implements GMP Clearance Temporary Process During COVID-19 Pandemic

The State Drug Regulatory Authorities overseas, responsible for the assessment of manufacturing standards according to GMP principle, have postponed the …

read more...

Vietnam Ministry of Health Updates Guidance Report of Bioavailability/Bioequivalence for Drug Registration

This Circular is issued on 5 Sept 2022, effective on 1 Nov 2022, and replaced the current guideline Circular 08-2010/TT-BYT …

read more...

Vietnam Ministry of Health Updates Guideline on Registration of Drug and Medicinal Materials

Circular 08/2022/TT-BYT (Circular stipulating the registration of DRUG, Medicinal materials) was issued on 5th September 2022 and will be implemented …

read more...

Singapore HSA Updates Guidance on Therapeutic Product Registration

The Health Sciences Authority (HSA) Singapore has published the updated guidance document on the regulatory processes and requirements for therapeutic …

read more...

Hong Kong Drug Office Publishes Frequently Asked Questions on Bioavailability and Bioequivalence Studies for Pharmaceutical Drugs

Hong Kong Drug Office has published a set of frequently asked questions on Phase 2 requirements of bioavailability (BA) and …

read more...

NPRA Malaysia Updates Variation Guideline for Pharmaceutical Products

The National Pharmaceutical Regulatory Agency (NPRA) Malaysia has published the second edition of the variation guideline for pharmaceutical products in …

read more...

Philippines FDA Publishes Circular on Labelling Requirements of Drug Products under Maximum Retail Price

The Philippines Food and Drug Administration (FDA) has issued FDA Circular No. 2022-005, which provides some information on the process …

read more...

More News